| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5c4697f61690ee45cc08d7a75d8531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_802b888ea9a67e468e397378436fa341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec1428f6fc6519dd9049704a5a4dec85 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1361751d656232d5f7c29c39e3260bb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff200721569b30ca14e4f642eb1fbcff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_411d3dc2669c2821114223780e0f6b1f |
| publicationDate |
2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012142320-A2 |
| titleOfInvention |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| abstract |
The described invention provides compositions and methods for preventing or treating a disease, condition, or pathologic process characterized by aberrant fibroblast proliferation and extracellular matrix deposition in a tissue of a subject. The method includes administering a therapeutic amount of a pharmaceutical composition comprising a polypeptide having the amino acid sequence YARAAARQARAKALARQLGVAA (SEQ ID NO: 1) or functional equivalent thereof, and a pharmaceutically acceptable carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3268022-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018501201-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3553076-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022204045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107106650-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015535233-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017509633-A |
| priorityDate |
2011-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |